Magle Chemoswed (MAGLE) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue fell to 71.7 MSEK from 85.1 MSEK year-over-year, reflecting operational challenges and delayed batch deliveries.

• EBITDA was -6.6 MSEK, impacted by 9–10 MSEK in exceptional restructuring costs; adjusted EBITDA would be approximately +10 MSEK on a proforma basis.

• Net loss after tax widened to -22.0 MSEK from -1.2 MSEK year-over-year.

• The group is undergoing a major turnaround, with new leadership, streamlined organization, and cost reductions.

Financial highlights

• Q1 2026 operating profit (EBIT) was -17.7 MSEK, down from 2.1 MSEK in Q1 2025.

• Revenue decline driven by production constraints and changes in royalty revenue recognition.

• Depreciation and amortization for the quarter was 11.2 MSEK, consistent with prior periods.

• Earnings per share for Q1 2026 was -1.07, compared to -0.07 in Q1 2025.

Outlook and guidance

• Management expects the turnaround to take 12–18 months, with improvements anticipated over coming quarters.

• Focus remains on restoring production, enforcing pricing and cost discipline, and implementing new business plans.